Gene · 85363
Papers2,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Predicting prognosis and clinical efficacy of immune checkpoint blockade therapy via interferon-alpha response in muscle-invasive bladder cancer. | Pathol Oncol Res | 2023 | 37082269 | PubTator, text mining | PubMed |
| A novel role of TRIM28 B box domain in L1 retrotransposition and ORF2p-mediated cDNA synthesis. | Nucleic Acids Res | 2023 | 37070200 | PubTator, text mining | PubMed |
| Trim-Away ubiquitinates and degrades lysine-less and N-terminally acetylated substrates. | Nat Commun | 2023 | 37061529 | PubTator, text mining | PubMed |
| Primary role of type I interferons for the induction of functionally optimal antigen-specific CD8+ T cells in HIV infection. | EBioMedicine | 2023 | 37058769 | PubTator, text mining | PubMed |
| Antiviral Properties of HIV-1 Capsid Inhibitor GSK878. | Antimicrob Agents Chemother | 2023 | 37039636 | PubTator, text mining | PubMed |
| The roles of nucleic acid editing in adaptation of zoonotic viruses to humans. | Curr Opin Virol | 2023 | 37031485 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| TRIM25 inhibits HBV replication by promoting HBx degradation and the RIG-I-mediated pgRNA recognition. | Chin Med J (Engl) | 2023 | 36975005 | PubTator, text mining | PubMed |
| IP6-stabilised HIV capsids evade cGAS/STING-mediated host immune sensing. | EMBO Rep | 2023 | 36970882 | PubTator, text mining | PubMed |
| The capsid lattice engages a bipartite NUP153 motif to mediate nuclear entry of HIV-1 cores. | Proc Natl Acad Sci U S A | 2023 | 36943880 | PubTator, text mining | PubMed |
| Host Cell Restriction Factors Blocking Efficient Vector Transduction: Challenges in Lentiviral and Adeno-Associated Vector Based Gene Therapies. | Cells | 2023 | 36899868 | PubTator, text mining | PubMed |
| Evolutionary honing in and mutational replacement: how long-term directed mutational responses to specific environmental pressures are possible. | Theory Biosci | 2023 | 36899155 | PubTator, text mining | PubMed |
| Strategies to overcome HIV drug resistance-current and future perspectives. | Front Microbiol | 2023 | 36876064 | PubTator, text mining | PubMed |
| Role of Jumonji domain-containing protein D3 and its inhibitor GSK-J4 in Hashimoto's thyroiditis. | Open Med (Wars) | 2023 | 36874364 | PubTator, text mining | PubMed |
| IFNAR signaling of neuroectodermal cells is essential for the survival of C57BL/6 mice infected with Theiler's murine encephalomyelitis virus. | J Neuroinflammation | 2023 | 36872323 | PubTator, text mining | PubMed |
| TRIM56 acts through the IQGAP1-CDC42 signaling axis to promote glioma cell migration and invasion. | Cell Death Dis | 2023 | 36870986 | PubTator, text mining | PubMed |
| Fine particulate matter (PM2.5)-induced pulmonary oxidative stress contributes to changes in the plasma lipidome and liver transcriptome in mice. | Toxicol Sci | 2023 | 36857595 | PubTator, text mining | PubMed |
| Overexpression of TRIM16 Reduces the Titer of H5N1 Highly Pathogenic Avian Influenza Virus and Promotes the Expression of Antioxidant Genes through Regulating the SQSTM1-NRF2-KEAP1 Axis. | Viruses | 2023 | 36851605 | PubTator, text mining | PubMed |
| The HIV Restriction Factor Profile in the Brain Is Associated with the Clinical Status and Viral Quantities. | Viruses | 2023 | 36851531 | PubTator, text mining | PubMed |
| DKK3's protective role in prostate cancer is partly due to the modulation of immune-related pathways. | Front Immunol | 2023 | 36845147 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/85363/papers?page=9